ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75 | -90.1% | 569,566 | -61.6% | 0.01% | -92.1% |
Q2 2023 | $756 | +8.8% | 1,481,793 | +34.3% | 0.08% | +10.1% |
Q1 2023 | $695 | +11.9% | 1,102,975 | +15.2% | 0.07% | -10.4% |
Q4 2022 | $621 | -99.9% | 957,348 | +57.4% | 0.08% | -44.6% |
Q3 2022 | $1,046,000 | -10.2% | 608,037 | -35.3% | 0.14% | -20.6% |
Q2 2022 | $1,165,000 | +666.4% | 939,214 | +304.1% | 0.18% | +775.0% |
Q1 2022 | $152,000 | +126.9% | 232,438 | +2088.7% | 0.02% | +400.0% |
Q1 2017 | $67,000 | -81.1% | 10,620 | -77.8% | 0.00% | -82.6% |
Q1 2016 | $355,000 | +143.2% | 47,819 | +171.7% | 0.02% | +228.6% |
Q4 2015 | $146,000 | +46.0% | 17,600 | +58.0% | 0.01% | +40.0% |
Q3 2015 | $100,000 | -57.1% | 11,142 | -42.6% | 0.01% | -44.4% |
Q2 2015 | $233,000 | – | 19,421 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |